Overview
- Collects data on approx. 50 radiopharmaceuticals
- Explores basic and clinical data along with essential references
- Presented in a consistent and accessible format
Part of the book series: Clinicians’ Guides to Radionuclide Hybrid Imaging (CGRHI)
Part of the book sub series: PET/CT (PET/CT)
Buy print copy
About this book
This book presents in a consistent format data on ~50 PET radiopharmaceuticals in clinical use. Parameters include basic chemical data, normal biodistribution and excretion, activity administered, radiation dosimetry, patient preparation, and clinical utility, together with a few key references. In some cases a representative image is presented. The organisation is first by clinical specialty (oncology, cardiology, neurology) and within each section by radionuclide (F-18, C-11, etc).
This book will be of interest mostly to nuclear medicine physicians and trainees, but also to a wider medical community including radiologists, oncologists and radiotherapists.
Similar content being viewed by others
Keywords
Table of contents (57 chapters)
-
Oncology—11C-Labelled Agents
-
-
Oncology—68Ga-Labelled Agents
-
Oncology—Other Agents
Authors and Affiliations
About the author
Bibliographic Information
Book Title: PET Radiopharmaceuticals
Book Subtitle: Chemical, Biological, and Clinical Data
Authors: James R. Ballinger
Series Title: Clinicians’ Guides to Radionuclide Hybrid Imaging
DOI: https://doi.org/10.1007/978-3-031-10271-4
Publisher: Springer Cham
eBook Packages: Medicine, Medicine (R0)
Copyright Information: The Editor(s) (if applicable) and The Author(s), under exclusive license to Springer Nature Switzerland AG 2022
Softcover ISBN: 978-3-031-10270-7Published: 02 November 2022
eBook ISBN: 978-3-031-10271-4Published: 01 November 2022
Edition Number: 1
Number of Pages: XX, 131
Topics: Nuclear Medicine, Imaging / Radiology, Oncology